Johnson & Johnson's second-quarter sales were $25.31 billion, higher than the previous forecast of $25.04 billion.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.